291 related articles for article (PubMed ID: 12910066)
1. [Two cases of non-functional gonadotroph adenoma pituitary apoplexy following GnRH-agonist treatment revealing gonadotroph adenoma and pseudopituitary apoplexy after GnRH administration].
Hernandez Morin N; Huet D; Hautecouverture M
Ann Endocrinol (Paris); 2003 Jun; 64(3):227-31. PubMed ID: 12910066
[TBL] [Abstract][Full Text] [Related]
2. Pituitary apoplexy of a gonadotroph adenoma following gonadotrophin releasing hormone agonist therapy for prostatic cancer.
Reznik Y; Chapon F; Lahlou N; Deboucher N; Mahoudeau J
J Endocrinol Invest; 1997 Oct; 20(9):566-8. PubMed ID: 9413812
[TBL] [Abstract][Full Text] [Related]
3. Pituitary apoplexy following gonadotropin-releasing hormone agonist administration with gonadotropin-secreting pituitary adenoma.
Sasagawa Y; Tachibana O; Nakagawa A; Koya D; Iizuka H
J Clin Neurosci; 2015 Mar; 22(3):601-3. PubMed ID: 25455737
[TBL] [Abstract][Full Text] [Related]
4. Pituitary apoplexy after leuprolide.
Davis A; Goel S; Picolos M; Wang M; Lavis V
Pituitary; 2006; 9(3):263-5. PubMed ID: 16832587
[TBL] [Abstract][Full Text] [Related]
5. Pituitary apoplexy induced by gonadotropin-releasing hormone (GnRH) agonist administration for treatment of prostate cancer: a systematic review.
Raj R; Elshimy G; Jacob A; Arya PVA; Unnikrishnan DC; Correa R; Myint ZW
J Cancer Res Clin Oncol; 2021 Aug; 147(8):2337-2347. PubMed ID: 34156518
[TBL] [Abstract][Full Text] [Related]
6. Discovery of a pituitary adenoma following a gonadotropin-releasing hormone agonist in a patient with prostate cancer.
Massoud W; Paparel P; Lopez JG; Perrin P; Daumont M; Ruffion A
Int J Urol; 2006 Mar; 13(3):303-4. PubMed ID: 16643633
[TBL] [Abstract][Full Text] [Related]
7. Infarction followed by hemorrhage in pituitary adenoma due to endocrine stimulation test.
Matsuura I; Saeki N; Kubota M; Murai H; Yamaura A
Endocr J; 2001 Aug; 48(4):493-8. PubMed ID: 11603573
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of follicle-stimulating hormone secretion from gonadotroph adenomas by repetitive administration of a gonadotropin-releasing hormone antagonist.
Daneshdoost L; Pavlou SN; Molitch ME; Gennarelli TA; Savino PJ; Sergott RC; Bosley TM; River JE; Vale WW; Snyder PJ
J Clin Endocrinol Metab; 1990 Jul; 71(1):92-7. PubMed ID: 2115048
[TBL] [Abstract][Full Text] [Related]
9. Pituitary apoplexy and sudden blindness following the administration of gonadotrophin releasing hormone.
Masson EA; Atkin SL; Diver M; White MC
Clin Endocrinol (Oxf); 1993 Jan; 38(1):109-10. PubMed ID: 8435878
[TBL] [Abstract][Full Text] [Related]
10. Pituitary apoplexy probably due to TRH and GnRH stimulation tests in a patient with acromegaly.
Dökmetaş HS; Selçuklu A; Colak R; Unlühizarci K; Bayram F; Keleştimur F
J Endocrinol Invest; 1999 Oct; 22(9):698-700. PubMed ID: 10595834
[TBL] [Abstract][Full Text] [Related]
11. Delayed pituitary apoplexy in patient with advanced prostate cancer treated with gonadotrophin-releasing hormone agonists.
Sinnadurai M; Cherukuri RK; Moses RG; Nasser E
J Clin Neurosci; 2010 Sep; 17(9):1201-3. PubMed ID: 20605467
[TBL] [Abstract][Full Text] [Related]
12. Pituitary apoplexy caused by luteinizing hormone-releasing hormone in prolactin-producing adenoma.
Hiroi N; Ichijo T; Shimojo M; Ueshiba H; Tsuboi K; Miyachi Y
Intern Med; 2001 Aug; 40(8):747-50. PubMed ID: 11518116
[TBL] [Abstract][Full Text] [Related]
13. Discovery of a pituitary adenoma following treatment with a gonadotropin-releasing hormone agonist in a patient with prostate cancer.
Massoud W; Paparel P; Lopez JG; Perrin P; Daumont M; Ruffion A
Int J Urol; 2006 Jan; 13(1):87-8. PubMed ID: 16448441
[TBL] [Abstract][Full Text] [Related]
14. Gonadotroph adenoma with secondary hypersecretion of testosterone.
Chamoun R; Layfield L; Couldwell WT
World Neurosurg; 2013 Dec; 80(6):900.e7-11. PubMed ID: 23201183
[TBL] [Abstract][Full Text] [Related]
15. New technique for quantitation of pituitary adenoma size: use in evaluating treatment of gonadotroph adenomas with a gonadotropin-releasing hormone antagonist.
McGrath GA; Goncalves RJ; Udupa JK; Grossman RI; Pavlou SN; Molitch ME; Rivier J; Vale WW; Snyder PJ
J Clin Endocrinol Metab; 1993 May; 76(5):1363-8. PubMed ID: 8496331
[TBL] [Abstract][Full Text] [Related]
16. Gonadotropin-releasing hormone agonist-induced pituitary apoplexy in treatment of prostate cancer: case report and review of literature.
Hands KE; Alvarez A; Bruder JM
Endocr Pract; 2007 Oct; 13(6):642-6. PubMed ID: 17954421
[TBL] [Abstract][Full Text] [Related]
17. Pituitary adenoma and apoplexy during GnRH agonist treatment for IVF - case report.
Stefaniak A; Domitrz J; Siewko K; Szelachowska M; Krętowski A; Stachura-Matyjewicz A
Gynecol Endocrinol; 2020 Jun; 36(6):561-563. PubMed ID: 31868050
[No Abstract] [Full Text] [Related]
18. Pituitary apoplexy after leuprolide administration for carcinoma of the prostate.
Morsi A; Jamal S; Silverberg JD
Clin Endocrinol (Oxf); 1996 Jan; 44(1):121-4. PubMed ID: 8706284
[TBL] [Abstract][Full Text] [Related]
19. Gonadotropin-releasing hormone-induced partial empty sella clinically mimicking pituitary apoplexy in a woman with a suspected non-secreting macroadenoma.
Foppiani L; Piredda S; Guido R; Spaziante R; Giusti M
J Endocrinol Invest; 2000 Feb; 23(2):118-21. PubMed ID: 10800766
[TBL] [Abstract][Full Text] [Related]
20. A spontaneous and severe hyperstimulation of the ovaries revealing a gonadotroph adenoma.
Christin-Maitre S; Rongières-Bertrand C; Kottler ML; Lahlou N; Frydman R; Touraine P; Bouchard P
J Clin Endocrinol Metab; 1998 Oct; 83(10):3450-3. PubMed ID: 9768644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]